Purple Biotech (Israel) Alpha and Beta Analysis
| KTOV Stock | ILA 7.20 0.20 2.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Purple Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Purple Biotech over a specified time horizon. Remember, high Purple Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Purple Biotech's market risk premium analysis include:
Beta (0.57) | Alpha (0.35) | Risk 16 | Sharpe Ratio (0.03) | Expected Return (0.56) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Purple |
Purple Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Purple Biotech market risk premium is the additional return an investor will receive from holding Purple Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Purple Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Purple Biotech's performance over market.| α | -0.35 | β | -0.57 |
Purple Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Purple Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Purple Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Purple Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Purple Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Purple Biotech shares will generate the highest return on investment. By understating and applying Purple Biotech stock market price indicators, traders can identify Purple Biotech position entry and exit signals to maximize returns.
Purple Biotech Return and Market Media
The median price of Purple Biotech for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 is 10.4 with a coefficient of variation of 39.34. The daily time series for the period is distributed with a sample standard deviation of 4.08, arithmetic mean of 10.37, and mean deviation of 3.72. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Purple Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Purple or other stocks. Alpha measures the amount that position in Purple Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Purple Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Purple Biotech's short interest history, or implied volatility extrapolated from Purple Biotech options trading.
Build Portfolio with Purple Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Purple Stock
When determining whether Purple Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Purple Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Purple Biotech Stock. Highlighted below are key reports to facilitate an investment decision about Purple Biotech Stock:Check out Purple Biotech Backtesting, Purple Biotech Valuation, Purple Biotech Correlation, Purple Biotech Hype Analysis, Purple Biotech Volatility, Purple Biotech History and analyze Purple Biotech Performance. For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Purple Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.